These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 11981616)

  • 1. Telomerase in brain tumors.
    Falchetti ML; Larocca LM; Pallini R
    Childs Nerv Syst; 2002 Apr; 18(3-4):112-7. PubMed ID: 11981616
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Telomerase activity in microdissected human gliomas.
    Weil RJ; Wu YY; Vortmeyer AO; Moon YW; Delgado RM; Fuller BG; Lonser RR; Remaley AT; Zhuang Z
    Mod Pathol; 1999 Jan; 12(1):41-6. PubMed ID: 9950161
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Meningiomas, dicentric chromosomes, gliomas, and telomerase activity.
    Carroll T; Maltby E; Brock I; Royds J; Timperley W; Jellinek D
    J Pathol; 1999 Aug; 188(4):395-9. PubMed ID: 10440750
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Telomerase activity and alterations in telomere length in human brain tumors.
    Hiraga S; Ohnishi T; Izumoto S; Miyahara E; Kanemura Y; Matsumura H; Arita N
    Cancer Res; 1998 May; 58(10):2117-25. PubMed ID: 9605755
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Telomerase activation in human cancers.
    Tsao SW; Zhang DK; Cheng RY; Wan TS
    Chin Med J (Engl); 1998 Aug; 111(8):745-50. PubMed ID: 11245033
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neural tumor-initiating cells have distinct telomere maintenance and can be safely targeted for telomerase inhibition.
    Castelo-Branco P; Zhang C; Lipman T; Fujitani M; Hansford L; Clarke I; Harley CB; Tressler R; Malkin D; Walker E; Kaplan DR; Dirks P; Tabori U
    Clin Cancer Res; 2011 Jan; 17(1):111-21. PubMed ID: 21208905
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The roles of telomeres and telomerase in cellular immortalization and the development of cancer.
    Klingelhutz AJ
    Anticancer Res; 1999; 19(6A):4823-30. PubMed ID: 10697595
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relation between telomerase activity, hTERT and telomere length for intracranial tumours.
    Maes L; Van Neste L; Van Damme K; Kalala JP; De Ridder L; Bekaert S; Cornelissen M
    Oncol Rep; 2007 Dec; 18(6):1571-6. PubMed ID: 17982646
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transglutaminase activity in human brain tumors.
    Röhn G; Ernestus RI; Schröder R; Hossmann KA; Klug N; Paschen W
    Acta Histochem Suppl; 1992; 42():155-8. PubMed ID: 1350103
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Telomeres, telomerase and development of cancer].
    Andersen TI
    Tidsskr Nor Laegeforen; 1998 May; 118(13):2043-6. PubMed ID: 9656791
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Telomeres, telomerase and cancer: is the magic bullet real?
    Sharma HW; Maltese JY; Zhu X; Kaiser HE; Narayanan R
    Anticancer Res; 1996; 16(1):511-5. PubMed ID: 8615664
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of telomeres and telomerase complex in haematological neoplasia: the length of telomeres as a marker of carcinogenesis and prognosis of disease.
    Gancarcíková M; Zemanová Z; Brezinová J; Berková A; Vcelíková S; Smigová J; Michalová K
    Prague Med Rep; 2010; 111(2):91-105. PubMed ID: 20653999
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Telomere DNA and telomerase of lymphoma-derived cell lines--telomere hypothesis for cell growth control].
    Yanagi K; Mochida A; Gotoh E
    Nihon Rinsho; 1997 Feb; 55(2):328-33. PubMed ID: 9046819
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Telomere dynamics and telomerase activation in tumor progression: prospects for prognosis and therapy.
    Healy KC
    Oncol Res; 1995; 7(3-4):121-30. PubMed ID: 8555645
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Telomerase activity and hTERT protein expression in meningiomas: an analysis in vivo versus in vitro.
    Maes L; Kalala JP; Cornelissen R; de Ridder L
    Anticancer Res; 2006; 26(3B):2295-300. PubMed ID: 16821605
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Telomerase subunits expression variation between biopsy samples and cell lines derived from malignant glioma.
    Shervington A; Patel R; Lu C; Cruickshanks N; Lea R; Roberts G; Dawson T; Shervington L
    Brain Res; 2007 Feb; 1134(1):45-52. PubMed ID: 17196947
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Telomere lengthening in telomerase-negative cells: the ends are coming together.
    Scheel C; Poremba C
    Virchows Arch; 2002 Jun; 440(6):573-82. PubMed ID: 12070595
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacological intervention strategies for affecting telomerase activity: future prospects to treat cancer and degenerative disease.
    Tárkányi I; Aradi J
    Biochimie; 2008 Jan; 90(1):156-72. PubMed ID: 17945408
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Telomere instability and cancer.
    Londoño-Vallejo JA
    Biochimie; 2008 Jan; 90(1):73-82. PubMed ID: 17728038
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A human cell line that maintains telomeres in the absence of telomerase and of key markers of ALT.
    Cerone MA; Autexier C; Londoño-Vallejo JA; Bacchetti S
    Oncogene; 2005 Nov; 24(53):7893-901. PubMed ID: 16116482
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.